Skip to main content
Erschienen in: Diabetologia 1/2010

01.01.2010 | Article

An empirical index of insulin sensitivity from short IVGTT: validation against the minimal model and glucose clamp indices in patients with different clinical characteristics

verfasst von: A. Tura, S. Sbrignadello, E. Succurro, L. Groop, G. Sesti, G. Pacini

Erschienen in: Diabetologia | Ausgabe 1/2010

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Minimal model analysis for insulin sensitivity has been validated against the glucose clamp and is an accepted method for estimating insulin sensitivity from IVGTT. However minimal model analysis requires a 3 h test and relevant expertise to run the mathematical model. The aim of this study was to suggest a simple predictor of minimal model analysis index using only 1 h IVGTT.

Methods

We studied participants with different clinical characteristics who underwent 3 h regular (n = 336) or insulin-modified (n = 160) IVGTT, or 1 h IVGTT and euglycaemic–hyperinsulinaemic clamp (n = 247). Measures of insulin sensitivity were insulin sensitivity index estimated by minimal model analysis (SI) and the mean glucose infusion rate (clamp) (M). A calculated SI (CSI) predictor, \({\text{CS}}_{{\text{I}}} = {\text{ $ \alpha $ }} \times {K_{\text G} } \mathord{\left/ {\vphantom {{K_{G} } {{\left( {{\Delta {\text{AUC}}_{{{\text{INS}}}} } \mathord{\left/ {\vphantom {{\Delta {\text{AUC}}_{{{\text{INS}}}} } T}} \right. \kern-\nulldelimiterspace} T} \right)}}}} \right. \kern-\nulldelimiterspace} {{\left( {{\Delta {\text{AUC}}_{{{\text{INS}}}} } \mathord{\left/ {\vphantom {{\Delta {\text{AUC}}_{{{\text{INS}}}} } T}} \right. \kern-\nulldelimiterspace} T} \right)}}\), was suggested, based on the calculation of the rate of glucose disappearance K G and the suprabasal AUC of insulin concentration ΔAUCINS over T = 40 min. For all the participants, α was assumed equal to the regression line slope between K G/(ΔAUCINS/T) and SI in control participants.

Results

CSI and SI showed high correlation (R 2 = 0.68–0.96) and regression line slopes of approximately one in the majority of groups. CSI tended to overestimate SI in type 2 diabetic participants, but results were more reliable when CSI was computed with insulin-modified rather than regular IVGTT. CSI showed behaviours similar to SI as regards relationships with BMI, acute insulin response and sex. CSI showed good correlation with M (R 2 = 0.82).

Conclusions/interpretation

A short test can achieve a good approximation of minimal model analysis and clamp insulin sensitivity. The importance of a method such as CSI is that it allows analysis of IVGTT datasets with samples limited to 1 h.
Literatur
1.
Zurück zum Zitat Bergman RN (1989) Toward physiological understanding of glucose tolerance. Minimal model approach. Diabetes 38:1512–1527CrossRefPubMed Bergman RN (1989) Toward physiological understanding of glucose tolerance. Minimal model approach. Diabetes 38:1512–1527CrossRefPubMed
2.
Zurück zum Zitat Saad MF, Anderson RL, Laws A et al (1994) A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Diabetes 43:1114–1121CrossRefPubMed Saad MF, Anderson RL, Laws A et al (1994) A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Diabetes 43:1114–1121CrossRefPubMed
3.
Zurück zum Zitat Morbiducci U, Di Benedetto G, Kautzky-Willer A, Pacini G, Tura A (2007) Improved usability of the minimal model of insulin sensitivity based on an automated approach and genetic algorithms for parameter estimation. Clin Sci (Lond) 112:257–263CrossRef Morbiducci U, Di Benedetto G, Kautzky-Willer A, Pacini G, Tura A (2007) Improved usability of the minimal model of insulin sensitivity based on an automated approach and genetic algorithms for parameter estimation. Clin Sci (Lond) 112:257–263CrossRef
4.
Zurück zum Zitat Amatuzio DS, Stutzman FL, Vanderbilt MJ, Nesbitt S (1953) Interpretation of the rapid intravenous glucose tolerance test in normal individuals and in mild diabetes mellitus. J Clin Invest 32:428–435CrossRefPubMed Amatuzio DS, Stutzman FL, Vanderbilt MJ, Nesbitt S (1953) Interpretation of the rapid intravenous glucose tolerance test in normal individuals and in mild diabetes mellitus. J Clin Invest 32:428–435CrossRefPubMed
5.
Zurück zum Zitat Viviani GL, Pacini G (1999) Reduced glucose effectiveness as a feature of glucose intolerance: evidence in elderly type-2 diabetic subjects. Aging 11:169–175PubMed Viviani GL, Pacini G (1999) Reduced glucose effectiveness as a feature of glucose intolerance: evidence in elderly type-2 diabetic subjects. Aging 11:169–175PubMed
6.
Zurück zum Zitat Fliser D, Pacini G, Engelleiter R et al (1998) Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease. Kidney Int 53:1343–1347CrossRefPubMed Fliser D, Pacini G, Engelleiter R et al (1998) Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease. Kidney Int 53:1343–1347CrossRefPubMed
7.
Zurück zum Zitat Kautzky-Willer A, Pacini G, Niederle B, Schernthaner G, Prager R (1992) Insulin secretion, insulin sensitivity and hepatic insulin extraction in primary hyperparathyroidism before and after surgery. Clin Endocrinol (Oxf) 37:147–155CrossRef Kautzky-Willer A, Pacini G, Niederle B, Schernthaner G, Prager R (1992) Insulin secretion, insulin sensitivity and hepatic insulin extraction in primary hyperparathyroidism before and after surgery. Clin Endocrinol (Oxf) 37:147–155CrossRef
8.
Zurück zum Zitat Rigotti P, Pacini G, Baldan N et al (1998) Insulin secretion in IDDM patients who have undergone successful pancreas–kidney transplantation. Transplant Proc 30:615–617CrossRefPubMed Rigotti P, Pacini G, Baldan N et al (1998) Insulin secretion in IDDM patients who have undergone successful pancreas–kidney transplantation. Transplant Proc 30:615–617CrossRefPubMed
9.
Zurück zum Zitat Pacini G, Tonolo G, Sambataro et al (1998) Insulin sensitivity and glucose effectiveness: minimal model analysis of regular and insulin-modified IVGTT. Am J Physiol Endocrinol Metab 274:E592–E599 Pacini G, Tonolo G, Sambataro et al (1998) Insulin sensitivity and glucose effectiveness: minimal model analysis of regular and insulin-modified IVGTT. Am J Physiol Endocrinol Metab 274:E592–E599
10.
Zurück zum Zitat Avogaro A, Miola M, Favaro A et al (2001) Gemfibrozil improves insulin sensitivity and flow-mediated vasodilatation in type 2 diabetic patients. Eur J Clin Invest 31:603–609CrossRefPubMed Avogaro A, Miola M, Favaro A et al (2001) Gemfibrozil improves insulin sensitivity and flow-mediated vasodilatation in type 2 diabetic patients. Eur J Clin Invest 31:603–609CrossRefPubMed
11.
Zurück zum Zitat Avogaro A, Watanabe RM, Dall’Arche A, de Kreutzenberg SV, Tiengo A, Pacini G (2004) Acute alcohol consumption improves insulin action without affecting insulin secretion in type 2 diabetic subjects. Diabetes Care 27:1369–1374CrossRefPubMed Avogaro A, Watanabe RM, Dall’Arche A, de Kreutzenberg SV, Tiengo A, Pacini G (2004) Acute alcohol consumption improves insulin action without affecting insulin secretion in type 2 diabetic subjects. Diabetes Care 27:1369–1374CrossRefPubMed
12.
Zurück zum Zitat Ludvik B, Hanefeld M, Pacini G (2008) Improved metabolic control by Ipomoea batatas (Caiapo) is associated with increased adiponectin and decreased fibrinogen levels in type 2 diabetic subjects. Diabetes Obes Metab 10:586–592CrossRefPubMed Ludvik B, Hanefeld M, Pacini G (2008) Improved metabolic control by Ipomoea batatas (Caiapo) is associated with increased adiponectin and decreased fibrinogen levels in type 2 diabetic subjects. Diabetes Obes Metab 10:586–592CrossRefPubMed
13.
Zurück zum Zitat Groop L, Forsblom C, Lehtovirta M et al (1996) Metabolic consequences of a family history of NIDDM (the Botnia study): evidence for sex-specific parental effects. Diabetes 45:1585–1593CrossRefPubMed Groop L, Forsblom C, Lehtovirta M et al (1996) Metabolic consequences of a family history of NIDDM (the Botnia study): evidence for sex-specific parental effects. Diabetes 45:1585–1593CrossRefPubMed
14.
Zurück zum Zitat Laakso M, Zilinskaite J, Hansen T et al (2008) EUGENE2 consortium: insulin sensitivity, insulin release and glucagon-like peptide-1 levels in persons with impaired fasting glucose and/or impaired glucose tolerance in the EUGENE2 study. Diabetologia 51:502–511CrossRefPubMed Laakso M, Zilinskaite J, Hansen T et al (2008) EUGENE2 consortium: insulin sensitivity, insulin release and glucagon-like peptide-1 levels in persons with impaired fasting glucose and/or impaired glucose tolerance in the EUGENE2 study. Diabetologia 51:502–511CrossRefPubMed
15.
Zurück zum Zitat Salinari S, Bertuzzi A, Asnaghi S, Guidone C, Manco M, Mingrone G (2009) First-phase insulin secretion restoration and differential response to glucose load depending on the route of administration in type 2 diabetic subjects after bariatric surgery. Diabetes Care 32:375–380CrossRefPubMed Salinari S, Bertuzzi A, Asnaghi S, Guidone C, Manco M, Mingrone G (2009) First-phase insulin secretion restoration and differential response to glucose load depending on the route of administration in type 2 diabetic subjects after bariatric surgery. Diabetes Care 32:375–380CrossRefPubMed
16.
Zurück zum Zitat Galvin P, Ward G, Walters J et al (1992) A simple method for quantitation of insulin sensitivity and insulin release from an intravenous glucose tolerance test. Diabet Med 9:921–928CrossRefPubMed Galvin P, Ward G, Walters J et al (1992) A simple method for quantitation of insulin sensitivity and insulin release from an intravenous glucose tolerance test. Diabet Med 9:921–928CrossRefPubMed
17.
Zurück zum Zitat Sherwin RS, Kramer KJ, Tobin JD et al (1974) A model of the kinetics of insulin in man. J Clin Invest 53:1481–1492CrossRefPubMed Sherwin RS, Kramer KJ, Tobin JD et al (1974) A model of the kinetics of insulin in man. J Clin Invest 53:1481–1492CrossRefPubMed
18.
Zurück zum Zitat Combleet PJ, Gochman N (1979) Incorrect least-squares regression coefficients in method-comparison analysis. Clin Chem 25:432–438 Combleet PJ, Gochman N (1979) Incorrect least-squares regression coefficients in method-comparison analysis. Clin Chem 25:432–438
19.
Zurück zum Zitat Anderson RL, Hamman RF, Savage PJ et al (1995) Exploration of simple insulin sensitivity measures derived from frequently sampled intravenous glucose tolerance (FSIGT) tests. The Insulin Resistance Atherosclerosis Study. Am J Epidemiol 142:724–732PubMed Anderson RL, Hamman RF, Savage PJ et al (1995) Exploration of simple insulin sensitivity measures derived from frequently sampled intravenous glucose tolerance (FSIGT) tests. The Insulin Resistance Atherosclerosis Study. Am J Epidemiol 142:724–732PubMed
20.
Zurück zum Zitat Pacini G, Ahrén M, Ahren B (2009) Reappraisal of the intravenous glucose tolerance index for a simple assessment of insulin sensitivity in mice. Am J Physiol Regul Integr Comp Physiol 296:R1316–R1324PubMed Pacini G, Ahrén M, Ahren B (2009) Reappraisal of the intravenous glucose tolerance index for a simple assessment of insulin sensitivity in mice. Am J Physiol Regul Integr Comp Physiol 296:R1316–R1324PubMed
21.
Zurück zum Zitat Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419CrossRefPubMed Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419CrossRefPubMed
22.
Zurück zum Zitat Stumvoll M, Mitrakou A, Pimenta W et al (2000) Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 23:295–301CrossRefPubMed Stumvoll M, Mitrakou A, Pimenta W et al (2000) Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 23:295–301CrossRefPubMed
23.
Zurück zum Zitat Haffner SM, D’Agostino R Jr, Festa A et al (2003) Low insulin sensitivity (S(i) = 0) in diabetic and nondiabetic subjects in the insulin resistance atherosclerosis study: is it associated with components of the metabolic syndrome and nontraditional risk factors? Diabetes Care 26:2796–2803CrossRefPubMed Haffner SM, D’Agostino R Jr, Festa A et al (2003) Low insulin sensitivity (S(i) = 0) in diabetic and nondiabetic subjects in the insulin resistance atherosclerosis study: is it associated with components of the metabolic syndrome and nontraditional risk factors? Diabetes Care 26:2796–2803CrossRefPubMed
24.
Zurück zum Zitat Mari A (1997) Assessment of insulin sensitivity with minimal model: role of model assumptions. Am J Physiol Endocrinol Metab 272:E925–E934 Mari A (1997) Assessment of insulin sensitivity with minimal model: role of model assumptions. Am J Physiol Endocrinol Metab 272:E925–E934
25.
26.
Zurück zum Zitat Finegood DT, Hramiak IM, Dupre J (1990) A modified protocol for estimation of insulin sensitivity with the minimal model of glucose kinetics in patients with insulin-dependent diabetes. J Clin Endocrinol Metab 70:1538–1549CrossRefPubMed Finegood DT, Hramiak IM, Dupre J (1990) A modified protocol for estimation of insulin sensitivity with the minimal model of glucose kinetics in patients with insulin-dependent diabetes. J Clin Endocrinol Metab 70:1538–1549CrossRefPubMed
27.
Zurück zum Zitat Kautzky-Willer A, Krssak M, Winzer C et al (2003) Increased intramyocellular lipid concentration identifies impaired glucose metabolism in women with previous gestational diabetes. Diabetes 52:244–251CrossRefPubMed Kautzky-Willer A, Krssak M, Winzer C et al (2003) Increased intramyocellular lipid concentration identifies impaired glucose metabolism in women with previous gestational diabetes. Diabetes 52:244–251CrossRefPubMed
28.
Zurück zum Zitat Bergman RN, Phillips LS, Cobelli C (1981) Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 68:1456–1467CrossRefPubMed Bergman RN, Phillips LS, Cobelli C (1981) Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 68:1456–1467CrossRefPubMed
29.
Zurück zum Zitat Kahn SE, Prigeon RL, McCulloch DK et al (1993) Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 42:1663–1672CrossRefPubMed Kahn SE, Prigeon RL, McCulloch DK et al (1993) Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 42:1663–1672CrossRefPubMed
30.
Zurück zum Zitat Ferrannini E, Mari A (2004) Beta cell function and its relation to insulin action in humans: a critical appraisal. Diabetologia 47:943–956CrossRefPubMed Ferrannini E, Mari A (2004) Beta cell function and its relation to insulin action in humans: a critical appraisal. Diabetologia 47:943–956CrossRefPubMed
31.
Zurück zum Zitat Pacini G (2006) The hyperbolic equilibrium between insulin sensitivity and secretion. Nutr Metab Cardiovasc Dis 16(Suppl 1):S22–S27CrossRefPubMed Pacini G (2006) The hyperbolic equilibrium between insulin sensitivity and secretion. Nutr Metab Cardiovasc Dis 16(Suppl 1):S22–S27CrossRefPubMed
32.
Zurück zum Zitat Tura A, Mari A, Prikoszovich T, Pacini G, Kautzky-Willer A (2008) Value of the intravenous and oral glucose tolerance tests for detecting subtle impairments in insulin sensitivity and beta-cell function in former gestational diabetes. Clin Endocrinol (Oxf) 69:237–243CrossRef Tura A, Mari A, Prikoszovich T, Pacini G, Kautzky-Willer A (2008) Value of the intravenous and oral glucose tolerance tests for detecting subtle impairments in insulin sensitivity and beta-cell function in former gestational diabetes. Clin Endocrinol (Oxf) 69:237–243CrossRef
33.
Zurück zum Zitat Garca-Estévez DA, Araújo-Vilar D, Saavedra-González A, Fiestras-Janeiro G, Cabezas-Cerrato J (2004) Analysis of the relationship between body mass index, insulin resistance, and beta-cell function: a cross-sectional study using the minimal model. Metabolism 53:1462–1466CrossRefPubMed Garca-Estévez DA, Araújo-Vilar D, Saavedra-González A, Fiestras-Janeiro G, Cabezas-Cerrato J (2004) Analysis of the relationship between body mass index, insulin resistance, and beta-cell function: a cross-sectional study using the minimal model. Metabolism 53:1462–1466CrossRefPubMed
34.
Zurück zum Zitat Clausen JO, Borch-Johnsen K, Ibsen H et al (1996) Insulin sensitivity index, acute insulin response, and glucose effectiveness in a population-based sample of 380 young healthy Caucasians. Analysis of the impact of gender, body fat, physical fitness, and life-style factors. J Clin Invest 98:1195–1209CrossRefPubMed Clausen JO, Borch-Johnsen K, Ibsen H et al (1996) Insulin sensitivity index, acute insulin response, and glucose effectiveness in a population-based sample of 380 young healthy Caucasians. Analysis of the impact of gender, body fat, physical fitness, and life-style factors. J Clin Invest 98:1195–1209CrossRefPubMed
35.
Zurück zum Zitat Zhang Y, Wat N, Stratton IM et al (1996) UKPDS 19: heterogeneity in NIDDM: separate contributions of IRS-1 and beta 3-adrenergic-receptor mutations to insulin resistance and obesity respectively with no evidence for glycogen synthase gene mutations. UK Prospective Diabetes Study. Diabetologia 39:1505–1511CrossRefPubMed Zhang Y, Wat N, Stratton IM et al (1996) UKPDS 19: heterogeneity in NIDDM: separate contributions of IRS-1 and beta 3-adrenergic-receptor mutations to insulin resistance and obesity respectively with no evidence for glycogen synthase gene mutations. UK Prospective Diabetes Study. Diabetologia 39:1505–1511CrossRefPubMed
36.
Zurück zum Zitat Marcovina S, Bowsher RR, Miller WG et al (2007) Standardization of insulin immunoassays: report of the American Diabetes Association Workgroup. Clin Chem 53:711–716CrossRefPubMed Marcovina S, Bowsher RR, Miller WG et al (2007) Standardization of insulin immunoassays: report of the American Diabetes Association Workgroup. Clin Chem 53:711–716CrossRefPubMed
Metadaten
Titel
An empirical index of insulin sensitivity from short IVGTT: validation against the minimal model and glucose clamp indices in patients with different clinical characteristics
verfasst von
A. Tura
S. Sbrignadello
E. Succurro
L. Groop
G. Sesti
G. Pacini
Publikationsdatum
01.01.2010
Verlag
Springer-Verlag
Erschienen in
Diabetologia / Ausgabe 1/2010
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-009-1547-9

Weitere Artikel der Ausgabe 1/2010

Diabetologia 1/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.